Agilon Health, Inc. (NYSE:AGL) Given Average Rating of “Hold” by Brokerages

Shares of Agilon Health, Inc. (NYSE:AGL) have been assigned an average recommendation of “Hold” from the fifteen analysts that are currently covering the company, Marketbeat.com reports. Two equities research analysts have rated the stock with a sell recommendation, eight have issued a hold recommendation and five have issued a buy recommendation on the company. The average 1 year target price among brokerages that have issued ratings on the stock in the last year is $58.7273.

A number of research analysts have weighed in on the company. Wall Street Zen upgraded Agilon Health from a “sell” rating to a “hold” rating in a research note on Saturday, May 9th. Barclays upgraded Agilon Health from an “underweight” rating to an “equal weight” rating and set a $81.00 price objective on the stock in a research note on Tuesday, May 26th. Wells Fargo & Company reissued an “overweight” rating and issued a $72.00 target price (up from $37.50) on shares of Agilon Health in a research note on Friday, May 8th. Weiss Ratings downgraded shares of Agilon Health from a “sell (d-)” rating to a “sell (e+)” rating in a report on Wednesday, May 27th. Finally, Citigroup reaffirmed a “neutral” rating and set a $80.00 price target (up from $18.75) on shares of Agilon Health in a research report on Friday, May 15th.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently made changes to their positions in AGL. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. grew its position in shares of Agilon Health by 3.5% in the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 214,200 shares of the company’s stock valued at $927,000 after purchasing an additional 7,209 shares during the last quarter. Dynamic Technology Lab Private Ltd grew its stake in shares of Agilon Health by 28.4% in the first quarter. Dynamic Technology Lab Private Ltd now owns 47,111 shares of the company’s stock valued at $204,000 after acquiring an additional 10,424 shares in the last quarter. Apollon Wealth Management LLC grew its stake in shares of Agilon Health by 17.4% in the fourth quarter. Apollon Wealth Management LLC now owns 82,348 shares of the company’s stock valued at $57,000 after acquiring an additional 12,193 shares in the last quarter. Legal & General Group Plc increased its position in Agilon Health by 4.1% during the second quarter. Legal & General Group Plc now owns 346,031 shares of the company’s stock worth $796,000 after acquiring an additional 13,700 shares during the period. Finally, Symphony Financial Services Inc. raised its stake in Agilon Health by 51.6% in the 3rd quarter. Symphony Financial Services Inc. now owns 47,000 shares of the company’s stock worth $48,000 after purchasing an additional 16,000 shares in the last quarter.

Agilon Health Trading Up 9.0%

NYSE:AGL opened at $116.93 on Friday. The company has a market cap of $1.95 billion, a P/E ratio of -5.42 and a beta of 3.02. Agilon Health has a twelve month low of $7.48 and a twelve month high of $119.25. The business has a 50 day moving average price of $75.82 and a two-hundred day moving average price of $37.30. The company has a quick ratio of 1.04, a current ratio of 1.04 and a debt-to-equity ratio of 0.08.

Agilon Health (NYSE:AGL) last announced its quarterly earnings data on Wednesday, May 6th. The company reported $1.80 earnings per share for the quarter, beating the consensus estimate of $1.04 by $0.76. The company had revenue of $1.42 billion during the quarter, compared to analysts’ expectations of $1.38 billion. Agilon Health had a negative return on equity of 146.03% and a negative net margin of 6.09%. As a group, analysts expect that Agilon Health will post -3.5 EPS for the current fiscal year.

About Agilon Health

Agilon Health (NYSE: AGL) is a healthcare company that partners with independent primary care physicians to deliver value-based care for Medicare beneficiaries. Through risk-sharing arrangements, Agilon assumes financial responsibility for patient populations, enabling physicians to focus on preventive and proactive health management. The company provides the administrative, clinical and operational infrastructure needed to support comprehensive care delivery.

Agilon’s platform encompasses data analytics, care management, patient engagement tools and population health programs.